{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1093/NAR/GKAA945",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/kinasemd",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web service",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0602"
        },
        {
          "@id": "edam:topic_0202"
        },
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_0154"
        },
        {
          "@id": "edam:topic_0199"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1093/NAR/GKAA945"
        },
        "pubmed:33137204"
      ],
      "sc:description": "Kinase mutations and drug response database.\n\nMutations in kinases are abundant and critical to study signaling pathways and regulatory roles in human disease, especially in cancer. Somatic mutations in kinase genes can affect drug treatment, both sensitivity and resistance, to clinically used kinase inhibitors.",
      "sc:featureList": [
        {
          "@id": "edam:operation_3227"
        },
        {
          "@id": "edam:operation_2421"
        }
      ],
      "sc:name": "KinaseMD",
      "sc:url": "https://bioinfo.uth.edu/kmd/"
    }
  ]
}